RYTM
Rhythm Pharmaceuticals Inc
NASDAQ: RYTM · HEALTHCARE · BIOTECHNOLOGY
$82.12
-2.45% today
Updated 2026-04-29
Market cap
$5.61B
P/E ratio
—
P/S ratio
29.55x
EPS (TTM)
$-3.11
Dividend yield
—
52W range
$55 – $122
Volume
0.9M
Rhythm Pharmaceuticals Inc (RYTM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-103.60%
Operating margin
-82.20%
ROE
-90.40%
ROA
-27.50%
Debt/equity
1.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-18.13M | — | — | — |
| 2013 | — | $-21.43M | — | — | — |
| 2014 | $0.00 | $-6.49M | — | — | — |
| 2015 | $0.00 | $-11.07M | — | — | — |
| 2016 | $0.00 | $-25.87M | — | — | — |
| 2017 | $0.00 | $-33.71M | — | — | — |
| 2018 | $0.00 | $-74.06M | — | — | — |
| 2019 | $0.00 | $-134.62M | — | — | — |
| 2020 | $35000.00 | $-130.73M | -1,971.43% | -390,214.29% | -373,505.71% |
| 2021 | $3.15M | $-68.01M | 81.01% | -5,391.85% | -2,156.21% |
| 2022 | $23.64M | $-181.12M | 90.98% | -757.92% | -766.22% |
| 2023 | $77.43M | $-184.68M | 87.99% | -238.10% | -238.52% |
| 2024 | $130.13M | $-260.60M | 89.73% | -204.04% | -200.27% |
| 2025 | $189.76M | $-196.54M | 89.73% | -101.19% | -103.57% |